Replies to post #229140 on Biotech Values

[DewDiligence]

TLSA +50% on what is essentially a refinement of its COVID-19 PR from one month ago:

https://www.globenewswire.com/news-release/2020/04/09/2014044/0/en/Tiziana-Lifesciences-Develops-Novel-Investigational-Treatment-For-Patients-Infected-with-COVID-19-Utilizing-Direct-Delivery-of-Anti-Interlukin-6-Receptor-Monoclonal-Antibodies.html